Vietnam Cell and Gene Therapy Market

Vietnam Cell and Gene Therapy Market Overview:

The Vietnam cell and gene therapy market size reached USD 86.17 Million in 2024. Looking forward, the market is expected to reach USD 294.24 Million by 2033, exhibiting a growth rate (CAGR) of 14.62% during 2025-2033. The market growth is driven by rising healthcare investment and infrastructure development, growing genetic technology advancement, and enhanced disease treatment innovation through precision medicine. Additionally, the expanding middle-class population and increasing demand for advanced medical treatments are supporting the Vietnam cell and gene therapy market share.

Vietnam Cell and Gene Therapy Market Trends:

Rising Healthcare Investment and Infrastructure Development

Vietnam's healthcare sector is experiencing unprecedented growth driven by substantial government and private investments in medical infrastructure. This financial commitment reflects the government's priority to upgrade medical facilities and expand access to advanced treatments. The aging population and reduced birth rate are increasing the demand for advanced healthcare services, especially in the specialty fields such as cell and gene therapy. Both public and private hospitals are also modernizing their facilities and establishing new departments to treat certain diseases and provide significant opportunities for more complex treatment. The central government has allowed large-scale national-level projects in terms of hospital upgrades and building, and huge sums of government money have been used to upgrade hospitals across the provinces.

Growing Genetic Technology Advancement

The Vietnamese genomics and genetic technology sector is experiencing remarkable expansion, positioning the country as an emerging hub for genetic innovation in Southeast Asia. This growth reflects increasing adoption of genetic testing, personalized medicine approaches, and advanced molecular diagnostics across the healthcare system. The Vietnam cell and gene therapy market growth is supported by rising awareness among healthcare providers and patients about the benefits of genetically-based treatments and diagnostics. Local firms are generating novel genetic testing technologies with Gene Solutions as the leading genetic testing company in the market in Vietnam, commanding over 80 percent market share in reproductive health tests. The increased competencies of the country in the development of genetic technology are evidenced by the fact that the company has developed a high level of liquid biopsy technology and cancer detection tools. The transference of knowledge and the adoption of technology are being promoted by international collaborations and partnerships, which are enhancing the swift rise in the genetic technology industry, as well as the establishment of positive environments that favor the development of the market.

Enhanced Disease Treatment Innovation Through Precision Medicine

Vietnam is witnessing a paradigm shift toward precision medicine and targeted therapeutic approaches, creating unprecedented opportunities for cell and gene therapy applications. The healthcare system is increasingly recognizing the potential of genetically based treatments to address previously untreatable conditions, particularly rare diseases and complex disorders. Vietnamese healthcare institutions are beginning to explore personalized treatment protocols that leverage genetic information to optimize therapeutic outcomes. The country's growing research capabilities and clinical expertise are enabling more sophisticated approaches to disease treatment, including the development of targeted therapies for cancer, genetic disorders, and other complex conditions. Local biotechnology companies are investing in research and development of innovative treatment solutions, with particular focus on cancers prevalent in the Vietnamese population. The integration of artificial intelligence and machine learning in genetic analysis is enhancing the precision of diagnostic and therapeutic approaches, supporting the growth of personalized medicine initiatives, and creating demand for advanced cell and gene therapy solutions.

Vietnam Cell and Gene Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels from 2025-2033. Our report has categorized the market based on therapy type, indication, delivery mode, and end user.

Therapy Type Insights:

• Cell Therapy
  • Stem Cell
    • Pluripotent Stem Cell
    • Cancer Stem Cell
    • Adult Stem Cell

• • Non-Stem Cell
    • T-Cell
    • Natural Killer Cell
    • Others
• Gene Therapy

The report has provided a detailed breakup and analysis of the market based on the therapy type. This includes cell therapy (stem cell (pluripotent stem cell, cancer stem cell, and adult stem cell) and non-stem cell (T-cell, natural killer cell, and others)), and gene therapy.

Indication Insights:

• Cardiovascular Disease
• Oncology Disorder
• Genetic Disorder
• Infectious Disease
• Neurological Disorder
• Others

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes cardiovascular disease, oncology disorder, genetic disorder, infectious disease, neurological disorder, and others.

Delivery Mode Insights:

• In-Vivo
• Ex-Vivo

The report has provided a detailed breakup and analysis of the market based on the delivery mode. This includes in-vivo and ex-vivo.

End User Insights:

• Hospitals
• Cancer Care Centers
• Pharmaceuticals and Biotechnology Companies
• Others

A detailed breakup and analysis of the market based on end user have also been provided in the report. This includes hospitals, cancer care centers, pharmaceuticals and biotechnology companies, and others.

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Vietnam Cell and Gene Therapy Market Report Coverage:

Key Questions Answered in This Report:

• How has the Vietnam cell and gene therapy market performed so far and how will it perform in the coming years?
• What is the breakup of the Vietnam cell and gene therapy market on the basis of therapy type?
• What is the breakup of the Vietnam cell and gene therapy market on the basis of indication?
• What is the breakup of the Vietnam cell and gene therapy market on the basis of delivery mode?
• What is the breakup of the Vietnam cell and gene therapy market on the basis of end user?
• What is the breakup of the Vietnam cell and gene therapy market on the basis of region?
• What are the various stages in the value chain of the Vietnam cell and gene therapy market?
• What are the key driving factors and challenges in the Vietnam cell and gene therapy market?
• What is the structure of the Vietnam cell and gene therapy market and who are the key players?
• What is the degree of competition in the Vietnam cell and gene therapy market?

Key Benefits for Stakeholders:

• IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Vietnam cell and gene therapy market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Vietnam cell and gene therapy market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Vietnam cell and gene therapy industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.